What is the Buying Price of Poly Medicure Share?

The Buying Price of Poly Medicure share is 1401.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Poly Medicure Share at Choice?

To buy Poly Medicure stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Poly Medicure, choose your preferred order type, and place the trade.

What is the PE ratio of Poly Medicure Shares?

The Price-to-earnings (P/E) ratio of Poly Medicure shares is 42.16. You can compare it with the sector average for relative valuation.

What is the PB ratio of Poly Medicure Shares?

The Price to Book (P/B) ratio Poly Medicure shares is 4.37. Useful to assess the stock's value relative to its book value.

Is Poly Medicure Overvalued?

To assess Poly Medicure’s valuation compare Sector P/E, P/B which are 50.56 & 3.12 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Poly Medicure?

The Market Cap of Poly Medicure is 14241.01 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Poly Medicure Share Price?

The 52 week high and low prices of Poly Medicure share price is 2316.6 & 1182. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Poly Medicure belong to?

Poly Medicure belongs to the Healthcare sector.

Poly Medicure Share price

POLYMED

Healthcare Large Cap

1401.3

3.70 (-0.26%)

NSE

BSE

Last updated on 5 Jun, 2026 | 12:33 IST

BuySell

Today's High

1435.00

Today's Low

1384.00

52 Week Low

1182.00

52 Week High

2316.60

Poly Medicure Chart

ChartIQ

TradingView

Poly Medicure Share Key Metrics

Volume

2.03 L

Market Cap

14241.01 CR

LTQ@LTP

4@1401.30

ATP

1409.34

Var Margin

21.73 %

Circuit Range

1124-1686

Delivery %

0 %

Value

28.58 CR

ASM/GSM

No

Market Lot

1

Summary

5 Jun, 2026 | 12:33 को, Poly Medicure का शेयर प्राइस आज ₹1401.3 पर है, जो दिन के लिए 3.70% की -0.26 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1384.00 और ₹1435.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1182.00 से ₹2316.60 तक रही है। ट्रेडिंग गतिविधि के मामले में, Poly Medicure ने 202772 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹101359490 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹140934 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 4,140130 रही। यह स्टॉक ₹1124-1686 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹28.58 CR है। दिन के लिए डिलीवरी परसेंटेज % रही। इसके अतिरिक्त, Poly Medicure वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Poly Medicure Fundamentals

P/E Ratio

42.16

P/B Ratio

4.37

Div. Yield

0.26

Sector P/E

50.56

Sector P/B

3.12

Sec. Div. Yield

0.05

Poly Medicure Resistance and Support

Pivot 1383.57

Resistance

First Resistance

1436.44

Second Resistance

1467.87

Third Resistance

1520.74

Support

First Support

1352.14

Second Support

1299.27

Third Support

1267.84

Poly Medicure Shareholding Pattern

2024-25
2023-24
2022-23
2021-22
2020-21
2019-20
2018-19
2016-17
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

53.16%

Mutual Fund

4.18%

Insurance

1.11%

Foreign Institutional Investors

14.1%

Domestic Institutional Investors

0.16%

Retail

27.29%

Others

0%

Total Promoters

MAR '23

53.31%

JUN '23

53.31%

SEP '23

53.16%

DEC '23

53.16%

Poly Medicure Corporate Actions

Date	Agenda
2026-05-25	Audited Results & Final Dividend
2026-02-05	Quarterly Results

Poly Medicure News

Poly Medicure Ltd - 531768 - Intimation Of Analyst/Investor Meet

Poly Medicure will hold a one-on-one meeting with investor Bay Capital on June 8, 2026, at its Faridabad plant. The company confirmed that no unpublished price sensitive information will be shared during the meeting.

Jun 03 2026 17:19:13

Poly Medicure Limited

Poly Medicure Limited appointed Mr. Indranil Mukherjee as Chief Executive Officer for Asia Pacific and India Business, effective June 1, 2026. This appointment brings a seasoned medical technology executive with 30 years of leadership experience to the company.

Jun 01 2026 18:59:03

Poly Medicure Ltd - 531768 - Announcement under Regulation 30 (LODR)-Change in Management

Poly Medicure appointed Mr. Indranil Mukherjee as Chief Executive Officer, Asia Pacific and India Business, effective June 1, 2026. He brings over 30 years of leadership experience in medical technology.

Jun 01 2026 18:58:10

Poly Medicure Limited

Poly Medicure Limited appointed Mr. Indranil Mukherjee as Chief Executive Officer for Asia Pacific and India Business, effective June 1, 2026. This appointment aims to strengthen regional leadership and drive business growth.

Jun 01 2026 18:54:31

Poly Medicure shares down 15% in three sessions after Q4 results; Here's what the management said

Poly Medicure reported a consolidated net profit decline of 27.8% year-on-year to ₹66.3 crore for Q4 FY26, despite revenue growing 21.25% to ₹534.5 crore. The profitability was impacted by significant margin compression, driven by surging employee and interest costs. The board recommended a dividend of ₹3.5 per share, and management issued a positive revenue guidance for FY27.

May 27 2026 13:17:44

Poly Medicure Ltd - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Poly Medicure informed that the audio recording of its earnings conference call, held on May 25, 2026, to discuss the audited Q4 FY26 standalone and consolidated financial results, is now accessible on the company's website.

May 25 2026 19:15:56

Poly Medicure Ltd - 531768 - Board Meeting Outcome for Poly Medicure Limited Has Submitted To The Exchange, The Audited Financial Results(Standalone & Consolidated) For The Quarter And Year Ended March 31, 2026.

Poly Medicure's board approved Q4 FY26 cons. results with revenue at ₹534.51 cr (up 21.25% YoY) and net profit at ₹65.04 cr (down 29.28% YoY). A dividend of ₹3.50 per share for FY26 was recommended, along with re-appointment of internal auditors.

May 25 2026 15:21:44

Poly Medicure Limited

Poly Medicure's QIP proceeds utilization report revealed deviation from offer document, with unutilized funds of Rs.71.87 crore invested in hybrid mutual funds, exposing them to market risks. Additionally, capital expenditure projects face implementation delays, rescheduling targets to FY27-FY28.

May 15 2026 20:22:15

Poly Medicure Ltd - 531768 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Poly Medicure's monitoring agency report for Q4 FY26 highlights deviations in the utilization of QIP funds. Unutilized proceeds amounting to Rs.7,187.58 lakh were invested in hybrid mutual funds with equity exposure, contrary to the QIP placement document. Additionally, manufacturing facility projects, including the SEZ Jaipur project, are delayed, with expenditure now rescheduled to FY27-28.

May 15 2026 20:20:32

Poly Medicure Limited

POLY MEDICURE LIMITED board meeting is scheduled for May 25, 2026. The agenda includes the consideration and approval of the audited financial results for the quarter and financial year ended March 2026, along with a final dividend.

May 14 2026 17:56:49

Name	Position
Devendra Mehta	Chairman
Jugal Kishore Baid	Non Independent & Non Executive Director

Poly Medicure Similar Stocks

Jubilant Pharmova Ltd.

971.30

0.60 (0.06%)

Caplin Point Laboratories Ltd.

2041.70

22.00 (1.09%)

Dr. Agarwal's Health Care Ltd.

459.10

-5.90 (1.27%)

Alembic Pharmaceuticals Ltd.

743.20

5.65 (0.77%)

Rainbow Children's Medicare Ltd.

1337.90

-9.10 (0.68%)

Vijaya Diagnostic Centre Ltd.

1373.10

13.70 (1.01%)

Concord Biotech Ltd.

1226.50

-11.70 (0.94%)

Alivus Life Sciences Ltd.

1033.60

-2.20 (0.21%)

Park Medi World Ltd.

285.80

-0.10 (0.03%)

Sanofi Consumer Healthcare India Ltd.

4764.10

61.50 (1.31%)

Poly Medicure FAQs

Poly Medicure शेयर का खरीद मूल्य 1401.3 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Poly Medicure शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Poly Medicure शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 42.16 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Poly Medicure शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.37 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Poly Medicure शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.12 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Poly Medicure का मार्केट कैप 14241.01 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Poly Medicure शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 2316.60 और 1182.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।